These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

648 related items for PubMed ID: 21721597

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Guidelines for treatment of pneumonia in intensive care units].
    Emmi V.
    Infez Med; 2005; Suppl():7-17. PubMed ID: 16801748
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. How good is the evidence for the recommended empirical antimicrobial treatment of patients hospitalized because of community-acquired pneumonia? A systematic review.
    Oosterheert JJ, Bonten MJ, Hak E, Schneider MM, Hoepelman IM.
    J Antimicrob Chemother; 2003 Oct; 52(4):555-63. PubMed ID: 12972448
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Current guidelines for the treatment of severe pneumonia and sepsis.
    Bodmann KF.
    Chemotherapy; 2005 Aug; 51(5):227-33. PubMed ID: 16103664
    [Abstract] [Full Text] [Related]

  • 7. Pneumococcal antimicrobial resistance: therapeutic strategy and management in community-acquired pneumonia.
    Aspa J, Rajas O, de Castro FR.
    Expert Opin Pharmacother; 2008 Feb; 9(2):229-41. PubMed ID: 18201146
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparative Efficacy of Beta-Lactams and Macrolides in the Treatment of Pediatric Pneumonia: A Systematic Review.
    Al Saeedy D, Gillani SW, Al-Salloum J, Moosvi A, Eissa M, Gulam SM.
    Curr Pediatr Rev; 2020 Feb; 16(4):307-313. PubMed ID: 32895041
    [Abstract] [Full Text] [Related]

  • 10. Antibacterial activity of 41 antimicrobials tested against over 2773 bacterial isolates from hospitalized patients with pneumonia: I--results from the SENTRY Antimicrobial Surveillance Program (North America, 1998).
    Mathai D, Lewis MT, Kugler KC, Pfaller MA, Jones RN, SENTRY Participants Group (North America).
    Diagn Microbiol Infect Dis; 2001 Feb; 39(2):105-16. PubMed ID: 11248523
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Diagnosis and management of community-acquired pneumonia in adults.
    Watkins RR, Lemonovich TL.
    Am Fam Physician; 2011 Jun 01; 83(11):1299-306. PubMed ID: 21661712
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Frequency of pathogen occurrence and antimicrobial susceptibility among community-acquired respiratory tract infections in the respiratory surveillance program study: microbiology from the medical office practice environment.
    Pfaller MA, Ehrhardt AF, Jones RN.
    Am J Med; 2001 Dec 17; 111 Suppl 9A():4S-12S; discussion 36S-38S. PubMed ID: 11755437
    [Abstract] [Full Text] [Related]

  • 16. Gatifloxacin phase IV surveillance trial (TeqCES study) utilizing 5000 primary care physician practices: report of pathogens isolated and susceptibility patterns in community-acquired respiratory tract infections.
    Pfaller MA, Jones RN.
    Diagn Microbiol Infect Dis; 2002 Sep 17; 44(1):77-84. PubMed ID: 12376036
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effect of β-Lactam Plus Macrolide Versus Fluoroquinolone on 30-Day Readmissions for Community-Acquired Pneumonia.
    Gilbert TT, Arfstrom RJ, Mihalovic SW, Dababneh AS, Varatharaj Palraj BR, Dierkhising RA, Mara KC, Lessard SR.
    Am J Ther; 2020 Sep 17; 27(2):e177-e182. PubMed ID: 30418221
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.